髓外多发性骨髓瘤的生物学与治疗
髓外多发性骨髓瘤(EMM)是多发性骨髓瘤的侵袭性亚型,其特征为亚克隆不依赖骨髓微环境生长,导致高增殖、凋亡逃逸和治疗耐药的高危状态。尽管多发性骨髓瘤患者总体生存改善,EMM 发生时结局普遍较差。本文讨论 EMM 的演化生物学、统一命名的重要性、预后意义及当前和新兴治疗策略。
要点
- EMM 是骨髓瘤侵袭性亚型,亚克隆不依赖骨髓微环境生长。
- EMM 与高增殖、凋亡逃逸和治疗耐药相关,结局普遍较差。
- 理解浆细胞归巢至骨髓外生态系统的分子机制对靶向微环境和信号通路至关重要。
核心结论
- EMM 是多发性骨髓瘤的侵袭性亚型,一旦发生通常结局较差,需理解其分子机制以开发靶向微环境和信号通路的策略。
研究设计与样本
- 本文为综述,讨论 EMM 的演化生物学、统一命名的重要性、预后意义及当前和新兴治疗策略。
主要发现
- EMM 的特征是亚克隆能够在骨髓微环境外生长,导致高增殖、凋亡逃逸和治疗耐药的高危状态。
- 近几十年来多发性骨髓瘤患者生存总体改善,但发生 EMM 时结局普遍较差。
临床怎么用
- 临床需认识 EMM 为高危亚型,关注统一命名和预后意义,并参考当前及新兴治疗策略进行管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Extramedullary multiple myeloma (EMM) is an aggressive subentity of multiple myeloma, characterized by the ability of a subclone to thrive and grow independent of the bone marrow microenvironment, resulting in a high-risk state associated with increased proliferation, evasion of apoptosis and treatment resistance. Despite improvement in survival for most patients with multiple myeloma over recent decades, outcomes are generally poor when EMM develops. Understanding the molecular underpinnings leading to homing of plasma cells in ecosystems outside the bone marrow will be crucial for therapeutically manipulating the microenvironment and targeting key signaling pathways. Herein, we discuss the evolutionary biology of EMM, underscore the importance of a uniform definition, discuss prognostic significance, and provide current and emerging treatment strategies for managing this rare subentity of multiple myeloma.
引用
- Bhutani M, Foureau DM, Atrash S, et al. Extramedullary multiple myeloma. Leukemia. 2019. PMID: 31776467. doi:10.1038/s41375-019-0660-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。